Skip to main content
. 2020 Feb 4;11:24. doi: 10.3389/fphar.2020.00024

Figure 4.

Figure 4

(A) Schematic illustration of CC‐UCNP preparation and application. (B) TEM images of (a) UCNPs and (b) CC‐UCNPs. (C) Quantitative analysis of various nanoparticle uptakes at various times. (D) Flow cytometry analysis of MDA‐MB‐435 cells after incubation with various Cy5‐labeled nanoparticles. (E) In vivo upconversion luminescence (UCL) images of MDA‐MB‐435-bearing mice 24 h after intravenous injection of various nano-formulations (tumor sites are indicated by red circles). (F) Ex vivo UCL images of tumors 24 h after injection. Reproduced with permission from (Rao et al., 2016a).